Indian Immunologicals Limited Extract Export Data — India (DGFT 2022–2026)

Name: Indian Immunologicals Limited Extract Export Records India — #5 Exporter, 12 Shipments, $600.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Extract

India Pharmaceutical Trade Intelligence

$12.1M292 Suppliers109 CountriesHS 30049099

ExportsIndia → PHILIPPINES13.7%India → UNITED ARAB9.8%

#1 Supplier: DABUR INDIA #1 Buyer: REGENCY PHARMA

Indian Immunologicals Limited — Extract Exporter #5 | $600.0K Trade Value | TransData Nexus | TransData Nexus

Indian Immunologicals Limited — Extract Exporter Profile

Indian Pharmaceutical Exporter · #5 for Extract · $600.0K export value · DGFT Verified

Indian Immunologicals Limited is the #5 Indian exporter of Extract with $600.0K in export value and 12 verified shipments. Indian Immunologicals Limited holds a 4.9% market share in Extract exports across 1 countries. The company exports 3 pharmaceutical products worth $29.1M across 3 therapeutic categories.

Indian Immunologicals Limited — Extract Export Profile: Buyers & Destinations

Indian Immunologicals Limited Extract export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Extract?

Country	Value	Shipments	Share
PHILIPPINES	$1.3M	25	13.6%
UNITED ARAB EMIRATES	$1.2M	260	12.9%
MYANMAR	$999.7K	26	10.9%
SINGAPORE	$973.3K	129

Who Are the Top Buyers of Extract from India?

Buyer	Country	Value	Orders
REGENCY PHARMA LIMITED	MAURITIUS	$806.6K	220
MEDI MYANMAR GROUP LTD	MYANMAR	$550.0K	11
UNAHCO INC	PHILIPPINES	$500.0K	10
INOVA PHARMACEUTICALS(SINGAPORE) PT	SINGAPORE	$402.1K	44
NATURELLE LLC	UNITED ARAB EMIRATES	$300.2K	25
DAVENBEN ENTERPRISES CORP	PHILIPPINES	$200.0K	4
ELBE PHARMA NIGERIA LIMITED	NIGERIA	$200.0K	4
DAILY - NEED INDUSTRIES LIMITED	NIGERIA	$194.7K	4
M/S DAVENBEN ENTERPRISES CORP	PHILIPPINES	$150.0K	3
MEDI MYANMAR GROUP LTD.	MYANMAR	$150.0K	3

India's Extract is purchased by 591 buyers worldwide. The top buyer is REGENCY PHARMA LIMITED (MAURITIUS), followed by MEDI MYANMAR GROUP LTD and UNAHCO INC.

How Does Indian Immunologicals Limited Compare to Nearest Extract Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	PANACEA BIOTEC PHARMA LIMITED	$723.4K	72	13	$10.0K
6	J B CHEMICALS AND PHARMACEUTICALS LIMITED	$625.8K	101	9	$6.2K
5	INDIAN IMMUNOLOGICALS LIMITED ★	$600.0K	12	1	$50.0K
3	TORRENT PHARMACEUTICALS LTD	$550.0K	11	2	$50.0K
2	LUMEN MARKETING COMPANY	$500.0K	10	1	$50.0K

Indian Immunologicals Limited ranks #5 among 292 Indian Extract exporters. Average shipment value of $50.0K compared to the market average of $22.5K. The closest competitors by value are PANACEA BIOTEC PHARMA LIMITED and J B CHEMICALS AND PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Extract Exports?

Port	Shipments	% Share
SAHAR AIR	385	17.9%
SAHAR AIR CARGO ACC (INBOM4)	238	11.1%
Bombay Air	128	6.0%
DELHI AIR	124	5.8%
NHAVA SHEVA SEA (INNSA1)	117	5.4%
DELHI AIR CARGO ACC (INDEL4)	101	4.7%
Delhi Air	82	3.8%
BANGALORE ICD (INWFD6)	74	3.4%

Geopolitical & Trade Policy Impact on Indian Immunologicals Limited's Extract Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like IIL. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing maritime carriers to suspend bookings and reroute vessels via the Cape of Good Hope. This has resulted in elongated lead times and increased shipping costs, disproportionately affecting time-sensitive pharmaceutical shipments. (pharmaceuticalcommerce.com) Additionally, the Middle East crisis has led to potential losses ranging between ₹2,500 crore and ₹5,000 crore for the Indian pharmaceutical industry due to supply chain disruptions. (outlookbusiness.com)

Conversely, escalating US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of new tariffs by the US administration, with rates reaching as high as 39% on imports from countries including India, poses a significant challenge. (apnews.com) These tariffs could impact nearly 55% of India's exports to the US, affecting long-standing client relationships and profit margins.

In the European Union, compliance with the Falsified Medicines Directive (FMD) has become imperative. Indian exporters must invest in serialization and traceability systems to meet these stringent requirements, ensuring continued access to the lucrative EU market.

Indian Immunologicals Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA and WHO intensifying inspections to ensure compliance with Good Manufacturing Practices (GMP). In 2023, the US FDA conducted over 200 inspections in India, with plans to increase this number in 2024, reflecting a growing emphasis on quality assurance. (fact.net.in) For IIL, maintaining rigorous quality standards is paramount, especially in light of incidents like the circulation of counterfeit batches of its rabies vaccine, Abhayrab®, in India since 2023. (health.gov.au) Such events underscore the necessity for robust quality control measures to safeguard product integrity and public trust.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Extract shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Indian Immunologicals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 109+ countries, 591+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Extract

Extract

Indian Immunologicals Limited — Extract Exporter Profile

Indian Immunologicals Limited — Extract Export Profile: Buyers & Destinations

Where Does India Export Extract?

Who Are the Top Buyers of Extract from India?

What Is India's Total Extract Export Value and How Much Does Indian Immunologicals Limited Contribute?

What Is the Average Shipment Value for Indian Immunologicals Limited's Extract Exports?

How Does Indian Immunologicals Limited Compare to Other Indian Extract Exporters?

Regulatory Requirements: Exporting Extract to Key Markets

United States — FDA

How Does Indian Immunologicals Limited Compare to Nearest Extract Exporters?

Which Indian Ports Ship Extract Exports?

Geopolitical & Trade Policy Impact on Indian Immunologicals Limited's Extract Exports

Indian Immunologicals Limited — Regulatory Compliance & Quality Standards

About Indian Immunologicals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Extract Export Data from Indian Immunologicals Limited

Extract Stats

Company Overview

Top Products by Indian Immunologicals Limited

Related Analysis

Need Detailed Export Data?

Data Source